Financing, Equity Capital Markets
Praxis Precision Medicines
01/24
|
$172.4 Million
Âé¶¹´«Ã½ served as bookrunner for Praxis Precision Medicines, Inc. on a confidentially marketed follow-on offering
Sub-Type
Confidentially Marketed Follow-On Offering
Sector
Sub-Sector
Biopharma